NGM Biopharmaceuticals In... (NGM)
NASDAQ: NGM
· Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM
NGM Biopharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -142.38M | -151.14M | -169.61M | -177.86M | -162.67M | -153.46M | -135.07M | -125.24M | -120.33M | -121.09M | -121.99M | -110.92M |
Depreciation & Amortization | 2.22M | 2.32M | 2.38M | 3.22M | 4.04M | 4.9M | 5.79M | 5.96M | 6.09M | 6.16M | 6.29M | 6.38M |
Stock-Based Compensation | 28.72M | 31.2M | 32.47M | 33.1M | 32.38M | 30.19M | 28.87M | 27.48M | 26.24M | 23.85M | 21.53M | 18.54M |
Other Working Capital | -20.92M | -21.55M | -4.52M | -18.05M | -23.92M | -16.16M | -21.49M | -3.99M | 8.63M | 3.48M | -5.49M | -4.53M |
Other Non-Cash Items | 9.73M | 780K | 886K | 592K | 2.52M | 5.27M | 4.59M | 8.82M | 7.05M | 5.01M | 5.02M | 178K |
Deferred Income Tax | -12.12M | -2.94M | -1.56M | n/a | n/a | 968K | 2M | 2.94M | 3.51M | 2.63M | 1.58M | 564K |
Change in Working Capital | -18.38M | -19.85M | -5.2M | -9.57M | -20.71M | -20.23M | -19.76M | -6.71M | 4.21M | 8.52M | -3.17M | -1.35M |
Operating Cash Flow | -132.2M | -139.64M | -140.63M | -150.53M | -144.44M | -132.37M | -113.58M | -86.74M | -73.23M | -74.93M | -90.74M | -86.61M |
Capital Expenditures | -1.25M | -1.5M | -1.52M | -2.24M | -1.86M | -1.55M | -1.44M | -1.81M | -1.68M | -1.82M | -1.79M | -1.47M |
Cash Acquisitions | n/a | -90.29M | -98.89M | -59.06M | -22.75M | -20.62M | 15.14M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -105.43M | -172.18M | -177.98M | -200.42M | -272.86M | -271.43M | -242.99M | -235.37M | -293.47M | -342.78M | -342.78M | -293.25M |
Sales Maturities Of Investments | 220.97M | 262.47M | 276.87M | 259.48M | 289.04M | 307.54M | 295.84M | 275.84M | 223.5M | 136.5M | 112.7M | 99.7M |
Other Investing Acitivies | n/a | 90.29M | 98.89M | 59.06M | 22.75M | 20.62M | -15.14M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 114.29M | 88.78M | 97.37M | 56.82M | 14.32M | 34.56M | 51.41M | 38.65M | -71.65M | -208.11M | -231.87M | -195.03M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.77M | 2.39M | 35.6M | 53.84M | 54.23M | 55.89M | 26.15M | 9.85M | 149.66M | 174.89M | 172.32M | 172.42M |
Financial Cash Flow | 1.77M | 2.39M | 35.6M | 53.84M | 54.23M | 55.89M | 26.15M | 9.85M | 149.66M | 174.89M | 172.32M | 172.42M |
Net Cash Flow | -16.14M | -48.47M | -7.65M | -39.87M | -75.88M | -41.92M | -36.02M | -38.24M | 4.78M | -108.15M | -150.29M | -109.21M |
Free Cash Flow | -133.45M | -141.15M | -142.15M | -152.77M | -146.3M | -133.92M | -115.02M | -88.55M | -74.91M | -76.76M | -92.53M | -88.08M |